PT1152757E - Inibidores de mmp no amolecimento do tecido conjuntivo - Google Patents

Inibidores de mmp no amolecimento do tecido conjuntivo

Info

Publication number
PT1152757E
PT1152757E PT00903808T PT00903808T PT1152757E PT 1152757 E PT1152757 E PT 1152757E PT 00903808 T PT00903808 T PT 00903808T PT 00903808 T PT00903808 T PT 00903808T PT 1152757 E PT1152757 E PT 1152757E
Authority
PT
Portugal
Prior art keywords
grounding
mmp inhibitors
conjunctive tissue
tissue
conjunctive
Prior art date
Application number
PT00903808T
Other languages
English (en)
Inventor
Mark William James Ferguson
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Publication of PT1152757E publication Critical patent/PT1152757E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Prostheses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Package Frames And Binding Bands (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
PT00903808T 1999-02-18 2000-02-14 Inibidores de mmp no amolecimento do tecido conjuntivo PT1152757E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9903598.2A GB9903598D0 (en) 1999-02-18 1999-02-18 Connective tissue healing

Publications (1)

Publication Number Publication Date
PT1152757E true PT1152757E (pt) 2005-09-30

Family

ID=10847938

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00903808T PT1152757E (pt) 1999-02-18 2000-02-14 Inibidores de mmp no amolecimento do tecido conjuntivo

Country Status (13)

Country Link
US (1) US6455569B1 (pt)
EP (1) EP1152757B1 (pt)
JP (1) JP2002537268A (pt)
AT (1) ATE299703T1 (pt)
AU (1) AU772470B2 (pt)
CA (1) CA2362279C (pt)
DE (1) DE60021350T2 (pt)
DK (1) DK1152757T3 (pt)
ES (1) ES2244410T3 (pt)
GB (1) GB9903598D0 (pt)
HK (1) HK1037960A1 (pt)
PT (1) PT1152757E (pt)
WO (1) WO2000048617A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436629B1 (en) * 2000-10-27 2002-08-20 The Regents Of The University Of California Modulating angiogenesis
EP2181704B1 (en) 2002-12-30 2015-05-06 Angiotech International Ag Drug delivery from rapid gelling polymer composition
US20070259030A1 (en) * 2006-05-05 2007-11-08 Drapeau Susan J Methods, systems and reagents for tendon and ligament therapy
RU2542471C2 (ru) 2006-11-15 2015-02-20 Коуда Терапьютикс, Инк. Улучшенные способы и композиции для заживления ран
US8323642B2 (en) * 2006-12-13 2012-12-04 Depuy Mitek, Inc. Tissue fusion method using collagenase for repair of soft tissue
WO2009085272A2 (en) 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Improved medical devices
JP2011507862A (ja) * 2007-12-21 2011-03-10 コーダ セラピューティクス， インコーポレイテッド 異常瘢痕または過剰瘢痕の治療のための抗コネキシン４３ポリヌクレオチドの使用
JP2011507856A (ja) * 2007-12-21 2011-03-10 コーダ セラピューティクス， インコーポレイテッド 整形外科状態の治療のための抗コネキシンポリヌクレオチド、ペプチド、または抗体の使用
AU2015305269B2 (en) 2014-08-22 2021-12-23 Auckland Uniservices Limited Channel modulators
WO2022128057A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for prevention and treatment of collagen degradation in human connecting tissue

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8827305D0 (en) * 1988-11-23 1988-12-29 British Bio Technology Compounds
US5239078A (en) * 1990-11-21 1993-08-24 Glycomed Incorporated Matrix metalloprotease inhibitors
US5318964A (en) * 1992-06-11 1994-06-07 Hoffmann-La Roche Inc. Hydroxamic derivatives and pharmaceutical compositions
US5310759A (en) 1992-08-12 1994-05-10 Bockman Richard S Methods of protecting and preserving connective and support tissues
JPH08511509A (ja) * 1993-04-07 1996-12-03 グリコメド・インコーポレイテッド 合成マトリックスメタロプロテアーゼ阻害剤およびその用途
GB9405076D0 (en) 1994-03-16 1994-04-27 Inst Of Ophtalmology A medical use of matrix metalloproteinase inhibitors
ES2170884T5 (es) * 1995-11-13 2007-04-01 Sanofi-Aventis Deutschland Gmbh Acidos alfa-iminohidroxamicos y carboxilicos n-sustituidos, ciclicos y heterociclicos.
DE19542189A1 (de) 1995-11-13 1997-05-15 Hoechst Ag Cyclische N-substituierte alpha-Iminohydroxamsäuren
GB9714936D0 (en) 1997-07-17 1997-09-17 Smith & Nephew Cell culture products

Also Published As

Publication number Publication date
WO2000048617A3 (en) 2001-02-08
CA2362279C (en) 2010-05-25
ES2244410T3 (es) 2005-12-16
WO2000048617A2 (en) 2000-08-24
ATE299703T1 (de) 2005-08-15
HK1037960A1 (en) 2002-03-01
GB9903598D0 (en) 1999-04-07
EP1152757B1 (en) 2005-07-20
DE60021350T2 (de) 2006-04-27
DE60021350D1 (de) 2005-08-25
JP2002537268A (ja) 2002-11-05
DK1152757T3 (da) 2005-10-31
CA2362279A1 (en) 2000-08-24
AU772470B2 (en) 2004-04-29
EP1152757A2 (en) 2001-11-14
AU2557100A (en) 2000-09-04
US6455569B1 (en) 2002-09-24

Similar Documents

Publication Publication Date Title
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
MY135732A (en) 5,6-trimethylenepyrimidin - 4 - one compounds
TR200103216T2 (tr) Pirimidinon bileşimleri
BR9916484A (pt) Combinações de inibidores do transporte de ácido biliar ileal e de agentes sequestrantes de ácido biliar em indicações cardiovasculares
ATE413386T1 (de) Ppar-gamma modulatoren
ATE404240T1 (de) Vorrichtung zur behandlung von biologischen geweben mittels elektrizität oder medikamenten
AU2209800A (en) Method of using a matrix metalloproteinase inhibitor and radiation therapy as combination therapy in the treatment of neoplasia
DE60023043D1 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
ATE420947T1 (de) Gewebeimplant zur wiederherstellung von knorpelgewebe
ATE225351T1 (de) Thienopyridin und thienopyrimidinderivate und ihre verwendung als entzündungshemmende mittel
ATE279181T1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
ATE350030T1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
TR200100774T2 (tr) Bir aP2 önleyicisinin ve kombinasyonunun kullanıldığı aterosklerozis tedavi yöntemi
BR9811099A (pt) Inibidores de urocinase
BR9913705A (pt) Métodos de tratamento de mieloma múltiplo e reabsorção de tecido ósseo induzido por mieloma utilizando antagonistas de integrin
PT1152757E (pt) Inibidores de mmp no amolecimento do tecido conjuntivo
DE60014928D1 (de) Retinoide zur behandlung von emphysem
HK1047707A1 (zh) (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途
MXPA04004372A (es) Derivados heterociclicos de glicinamida y su uso medico.
ATE359804T1 (de) Anwendung von alfa1beta1 integrinrezeptorinhibitoren und tgf-beta1- inhibitoren zur behandlung von nierenkrankheiten
ATE214272T1 (de) Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
BR0111158A (pt) Composto e sais fisiológicos do mesmo, método para tratar uma condição mediana por tnf-a em um paciente
MX9709910A (es) Compuestos que contienen arginina e imitaciones de arginina, su uso y composiciones que los contienen.
ATE543451T1 (de) Bioabsorbierbare, osteogenetische knochenplatte
ATE237346T1 (de) Gebrauch von galanin um nervenschäden zu reparieren